Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Munsell

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer|August 4, 2010
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinomaBrian M Slomovitz, Karen H Lu, Taren Johnston, et al.
Pediatric Blood & Cancer|March 12, 2011
Liposarcoma in children and young adults: a multi-institutional experienceWinston W Huh, Carrie Yuen, Mark Munsell, et al.
Cancer Research|November 3, 2004
The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemiaMarina Konopleva, Twee Tsao, Zeev Estrov, et al.
The Journal of Urology|October 20, 2009
Association between lymph node density and disease specific survival in patients with penile cancerRobert S Svatek, Mark Munsell, Jordan M Kincaid, et al.
Urologic Oncology|December 13, 2003
Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombiPaul Sweeney, Christopher G Wood, Louis L Pisters, et al.
Blood|April 20, 2004
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantationMarcos de Lima, Athanasios Anagnostopoulos, Mark Munsell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 29, 2004
Evaluation of patient chemotherapy education in a gynecology oncology centerJudith A Smith, Catherine C Kindo, Shiney Kurian, et al.
Blood|January 5, 2002
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemiaMarina Konopleva, Twee Tsao, Peter Ruvolo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha proteinWilliam F Benedict, Ziming Tao, Chang-Soo Kim, et al.
JMIR Formative Research|October 17, 2022
An Accessible Communication System for Population-Based Genetic Testing: Development and Usability StudyTara Coffin, Deborah Bowen, Elizabeth Swisher, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer|August 4, 2010
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinomaBrian M Slomovitz, Karen H Lu, Taren Johnston, et al.
Pediatric Blood & Cancer|March 12, 2011
Liposarcoma in children and young adults: a multi-institutional experienceWinston W Huh, Carrie Yuen, Mark Munsell, et al.
Cancer Research|November 3, 2004
The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemiaMarina Konopleva, Twee Tsao, Zeev Estrov, et al.
The Journal of Urology|October 20, 2009
Association between lymph node density and disease specific survival in patients with penile cancerRobert S Svatek, Mark Munsell, Jordan M Kincaid, et al.
Urologic Oncology|December 13, 2003
Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombiPaul Sweeney, Christopher G Wood, Louis L Pisters, et al.
Blood|April 20, 2004
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantationMarcos de Lima, Athanasios Anagnostopoulos, Mark Munsell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 29, 2004
Evaluation of patient chemotherapy education in a gynecology oncology centerJudith A Smith, Catherine C Kindo, Shiney Kurian, et al.
Blood|January 5, 2002
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemiaMarina Konopleva, Twee Tsao, Peter Ruvolo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha proteinWilliam F Benedict, Ziming Tao, Chang-Soo Kim, et al.
JMIR Formative Research|October 17, 2022
An Accessible Communication System for Population-Based Genetic Testing: Development and Usability StudyTara Coffin, Deborah Bowen, Elizabeth Swisher, et al.
Pageof 5